Mandibular Second Molar Protraction Assisted by Piezocision
Launched by JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Dec 19, 2018
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Twenty-six subjects (39 Molars) who presented with at least one extracted mandibular first molar were selected to participate in the study. The subjects were subdivided into one of 3 groups as follows: group 1 consisted of 18 molars (13 molars from patients with bilateral first molar extraction space and 5 molars from patients with unilateral first molar extraction space) where piezocision was performed immediately before molar protraction; group 2 consisted of 21 molars (13 from patients with bilateral first molar extraction space and 8 molars from patients with unilateral first molar extr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age range from 20 to 27 years
- • at least one extracted mandibular first molar (first molar extracted more than one year ago and residual extraction space more than 5 mm)
- • Class 1 malocclusion where molar protraction is indicated
- • all permanent teeth are present except for the extracted mandibular first molar/molars.
- • Exclusion Criteria:-
- • Ggingival index score \> 2
- • Plaque index score \> 2
- • Probing depth \> 4mm
- • Previous orthodontic treatment
- • Systemic disease and
- • Smoker.
About Jordan University Of Science And Technology
Jordan University of Science and Technology (JUST) is a leading academic institution dedicated to advancing research and innovation in the fields of science and technology. Committed to fostering a culture of excellence, JUST actively engages in clinical trials aimed at improving health outcomes and contributing to the medical community's knowledge base. With a robust framework for ethical research practices, the university collaborates with local and international partners to explore innovative solutions to pressing health challenges, thereby enhancing patient care and promoting scientific discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Elham S A Alhaija
Principal Investigator
Prof.- Main thesis supervisor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials